+91 9891296838/9811747774

ZELBORAF (vemurafenib) tablet
for oral use. Initial U.S. Approval: 2011 Available In India.

ZELBORAF (vemurafenib) tablet is a prescription medicine. ZELBORAF (vemurafenib) tablet is used to treat adults with unresectable or metastatic melanoma. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.

ZELBORAF (vemurafenib) tablet is a prescription medicine. ZELBORAF (vemurafenib) tablet is used to treat adults with unresectable or metastatic melanoma. ZELBORAF is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test.
Source content :

ZELBORAF (vemurafenib) tablet injection suppliers for India and other countries. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of ZELBORAF (vemurafenib) tablet injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ZELBORAF (vemurafenib) tablet injection medicine cost price in India.

The order for ZELBORAF (vemurafenib) tablet injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Vemurafenib (INN, marketed as Zelboraf) is an inhibitor of the B-Raf enzyme developed by Plexxikon (now part of Daiichi-Sankyo) and Genentech for the treatment of late-stage melanoma. The name "vemurafenib" comes from V600E mutated BRAF inhibition. Vemurafenib received FDA approval for the treatment of late-stage melanoma on August 17, 2011, making it the first drug designed using fragment-based lead discovery to gain regulatory approval. Vemurafenib later received Health Canada approval on February 15, 2012. On February 20, 2012, the European Commission approved vemurafenib as a monotherapy for the treatment of adult patients with BRAF V600E mutation positive unresectable or metastatic melanoma, the most aggressive form of skin cancer. On November 6, 2017, the FDA approved Vemurafenib for the treatment of some patients with Erdheim–Chester disease (ECD), a rare type of histiocytic neoplasm.

ZELBORAF (vemurafenib) tablet, for oral use.
Initial U.S. Approval: 2011

Tablet: 240 mg
Please see the Full Prescribing Information, including Patient Information, for ZELBORAF.
ZELBORAF (vemurafenib) tablet injection
You must agree before submitting.

News / Update for ZELBORAF (vemurafenib) tablet .

For ZELBORAF (vemurafenib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA nods for Roche’s Tecentriq plus Cotellic and Zelboraf for advanced melanoma For More Details

FDA Approves Tecentriq Combo for Certain Advanced Melanomas
Dated: APRIL 3, 2018


Steps to access ZELBORAF (vemurafenib) tablet.

Step 1. You send a request for your medicine online:- Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2. We verify your prescription and medical details:- Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3. We source your medicine:- Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4. We deliver your medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation under Named-Patient import

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

ZELBORAF (vemurafenib) tablet exporter and suppliers in India

Can I get anti-cancer medicines even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of -
ZELBORAF (vemurafenib) tablet in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ZELBORAF (vemurafenib) tablet in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ZELBORAF (vemurafenib) tablet in North America – Mexico.
ZELBORAF (vemurafenib) tablet in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ZELBORAF (vemurafenib) tablet in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ZELBORAF (vemurafenib) tablet in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ZELBORAF (vemurafenib) tablet in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ZELBORAF (vemurafenib) tablet in Australia and New Zealand.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur